Nomura Holdings
UTHR icon

Nomura Holdings’s United Therapeutics UTHR Stock Holding History

Nomura Holdings’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,100
Closed -$17.8M – 2063
2026
Q1 		$17.8M Buy
30,100
+3,600
+14% +$1.79M 0.05% 274
2025
Q4 		$12.9M Buy
26,500
+17,000
+179% +$7.92M 0.02% 439
2025
Q3 		$3.98M Buy
+9,500
New +$3.19M 0.01% 873
2025
Q2 		– Sell
-15,000
Closed -$4.62M – 1966
2025
Q1 		$4.62M Buy
+15,000
New +$5.14M 0.01% 738

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Nomura Holdings's UTHR Position: Q2 2026 in Review

Nomura Holdings reduced its United Therapeutics (UTHR) stake by 12% in Q2 2026, selling an estimated $1.26M and leaving 16,753 shares worth $9.08M. The position accounts for 0.01% of the portfolio, ranked #572.

Nomura Holdings first reported a position in UTHR in Q2 2013 and has held it in 25 quarters since. The position peaked at $20.8M in Q4 2025. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Nomura Holdings held 16,753 shares of United Therapeutics worth $9.08M as of Q2 2026.
  • Nomura Holdings sold 2,231 United Therapeutics shares in Q2 2026, an estimated $1.26M.
  • United Therapeutics made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #572 holding.
  • Nomura Holdings first reported a position in United Therapeutics in Q2 2013 and has held it in 25 quarters since.
  • Nomura Holdings's United Therapeutics position peaked at $20.8M in Q4 2025.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.